🛡️Level 4: Safety & Dosing

How can we prevent dangerous side effects before they happen?

100% PGx coverage prevents life-threatening toxicity before treatment starts. Personalized dosing with 83.1% toxicity reduction (PREPARE trial).

We've built the first system that prevents drug toxicity by identifying germline risks and recommending protective foods.

The Problem: Life-Threatening Toxicity Discovered Too Late

For patients with advanced, heavily pretreated cancer, clinicians need to know: ...

Problem

Pharmacogene Variants Undetected

DPYD, TPMT, UGT1A1 variants cause severe toxicity but aren't routinely screened

Problem

Pathway Overlap Unknown

Drug MoA overlaps with patient's germline vulnerabilities, multiplying risk

Problem

Generic Nutrition Advice

Patients get generic 'eat healthy' instead of pathway-specific foods

The Solution: Toxicity-Aware Nutrition

We've built the first system that prevents drug toxicity by identifying germline...

✓ Validated

Toxicity Pathway Detection

Identifies which biological pathways your drug stresses

✓ Validated

Mitigating Foods Mapping

Knows which foods support those pathways

✓ Validated

Personalized Timing

Knows when to take supplements (during vs

How Level 4 Works

Four steps to unlock this capability

1

Take CSI Score, Drug Selection, and Resistance Prediction from Levels 1-3

Input: CSI score + Drug selection + Resistance prediction + Germline variants
2

Add Genetic Safety Screening (PGx)

Input: Genetic safety screening (germline variants)
3

Predict Toxicity Risk and Pathway Overlap

Method: Pathway overlap analysis (DNA repair, inflammation, cardiometabolic)
4

Personalized Dosing and Protective Nutrition

Dosing: Personalized dosing recommendations (reduce dose 50-90% or avoid drug)
Complete Level 4 to Unlock:

CSI in Action: Continuous Monitoring

See how CSI updates automatically as tumor evolves. Track chemosensitivity across treatment lines with real-time alerts when CSI drops below threshold.

4

Level 4: Safety & Dosing

Prevent dangerous side effects before they happen

What You Can See:
All previous + Toxicity Alerts
Data Required:
+ Genetic safety screening (germline variants)

CSI Continuous Monitoring

Track CSI score updates as tumor evolves. Never miss a chemosensitivity change. • Patient AK

LIVE• Level 4 of 5 Unlocked
CSI Score
72/100
Decreased from 78

ChemoSensitivity Index

3/6/2026

CA-125
900
Plateau detected

Tumor Marker

2/28/2026

Imaging
No progression
Last scan: 3 weeks ago

CT Scans

2/14/2026

ctDNA
KRAS G12D: 0.8% VAF
New mutation detected

Liquid Biopsy

3/6/2026

Active Trials
3 matches
New trial added

Clinical Trials

3/5/2026

Resistance Alerts
Active
CSI dropping + new KRAS mutation

Early Warnings

Recent

Active Alerts & Insights

4 Active

CSI Score Decreased

Your CSI score dropped, meaning chemo is becoming less effective

CA-125 Plateau

Your CA-125 stopped declining and is staying flat

Resistance Mutation

New mutation detected in your blood that makes cancer resistant to current treatment

New Trial Match

A clinical trial that matches your specific tumor biology just opened

Unlock at Level 5: Complete Care Plan
Full monitoring timeline showing progression across all treatment lines will be available
5

Next: Level 5 - Complete Care Plan

Complete treatment timeline showing progression across all treatment lines

Unlocks:
All metrics + Full Timeline
Level 4 Validation

Level 4 Performance Metrics

Validated performance for this capability

Retrospective Tested

Validation Status

Validated performance for this capability